Perinatal Factors Affecting Coagulation Parameters at Birth in Preterm and Term Neonates: A Retrospective Cohort Study

Abstract

To date, few studies have investigated whether perinatal factors affect coagulation parameters at birth in preterm and term neonates. We retrospectively investigated coagulation factors on day 1 in 609 consecutive neonates admitted to our neonatal intensive care unit between January 2010 and December 2017. We measured coagulation factors on day 1 using peripheral blood samples. Multivariate analysis revealed that prothrombin time–international normalized ratio correlated with intraventricular hemorrhage (p = 0.000; β = 0.180) and placental abruption (PA; p = 0.000; β = 0.142). Activated partial thromboplastin time (aPTT) correlated with birth weight (BW; p = 0.000; β =  − 0.217), gestational age (GA; p = 0.000; β =  − 0.282), and PA (p = 0.000; β = 0.181). Fibrinogen concentration was associated with respiratory distress syndrome (p = 0.007; β =  − 0.114), pregnancy-induced hypertension (p = 0.000; β =  − 0.141), and Apgar score at 1 minute (p = 0.043; β = 0.147). Furthermore, the level of d-dimer inversely correlated with Apgar score at 5 minutes (p = 0.049). Finally, antithrombin III levels positively correlated with GA (p = 0.000) and BW (p = 0.000). Thus, maternal and neonatal complications affect coagulation parameters in preterm and term neonates.

Keywords

coagulation factors - preterm infants - neonatal complications

• References

• 1 McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008; 35 (04) 777-792
• 2 Kuperman AA, Brenner B, Kenet G. Intraventricular hemorrhage in preterm infants and coagulation--ambivalent perspectives?. Thromb Res 2013; 131 (Suppl. 01) S35-S38
• 3 Andrew M, Paes B, Milner R. , et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72 (05) 1651-1657
• 4 Barnard DR, Simmons MA, Hathaway WE. Coagulation studies in extremely premature infants. Pediatr Res 1979; 13 (12) 1330-1335
• 5 Andrew M, Paes B, Milner R. , et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70 (01) 165-172
• 6 Poralla C, Traut C, Hertfelder HJ, Oldenburg J, Bartmann P, Heep A. The coagulation system of extremely preterm infants: influence of perinatal risk factors on coagulation. J Perinatol 2012; 32 (11) 869-873
• 7 Seguin JH, Topper WH. Coagulation studies in very low-birthweight infants. Am J Perinatol 1994; 11 (01) 27-29
• 8 Neary E, Ni Ainle F, Cotter M, McCallion N. Coagulation values in extreme premature infants. Transfusion 2014; 54 (08) 2134
• 9 Duppré P, Sauer H, Giannopoulou EZ. , et al. Cellular and humoral coagulation profiles and occurrence of IVH in VLBW and ELWB infants. Early Hum Dev 2015; 91 (12) 695-700
• 10 Neary E, McCallion N, Kevane B. , et al. Coagulation indices in very preterm infants from cord blood and postnatal samples. J Thromb Haemost 2015; 13 (11) 2021-2030
• 11 Veldman A, Fischer D, Nold MF, Wong FY. Disseminated intravascular coagulation in term and preterm neonates. Semin Thromb Hemost 2010; 36 (04) 419-428
• 12 Keren-Politansky A, Breizman T, Brenner B, Sarig G, Drugan A. The coagulation profile of preterm delivery. Thromb Res 2014; 133 (04) 585-589
• 13 Salonvaara M, Riikonen P, Kekomäki R. , et al. Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants. Arch Dis Child Fetal Neonatal Ed 2003; 88 (04) F319-F323
• 14 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92 (04) 529-534
• 15 Monagle P, Barnes C, Ignjatovic V. , et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95 (02) 362-372
• 16 Monagle P, Massicotte P. Developmental haemostasis: secondary haemostasis. Semin Fetal Neonatal Med 2011; 16 (06) 294-300
• 17 Neary E, Okafor I, Al-Awaysheh F. , et al. Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit. Neonatology 2013; 104 (03) 222-227
• 18 Geens T, Vertessen F, Malfait R, Deiteren K, Maes MB. Validation of the Sysmex CS5100 coagulation analyzer and comparison to the Stago STA-R analyzer for routine coagulation parameters. Int J Lab Hematol 2015; 37 (03) 372-381
• 19 Boisramé T, Sananès N, Fritz G. , et al. Placental abruption: risk factors, management and maternal-fetal prognosis. Cohort study over 10 years. Eur J Obstet Gynecol Reprod Biol 2014; 179: 100-104
• 20 Tanjung MT, Siddik HD, Hariman H, Koh SC. Coagulation and fibrinolysis in preeclampsia and neonates. Clin Appl Thromb Hemost 2005; 11 (04) 467-473
• 21 Peters M, Ten Cate JW, Breederveld C, De Leeuw R, Emeis J, Koppe J. Low antithrombin III levels in neonates with idiopathic respiratory distress syndrome: poor prognosis. Pediatr Res 1984; 18 (03) 273-276
• 22 van den Berg W, Breederveld C, ten Cate JW, Peters M, Borm JJ. Low antithrombin III: accurate predictor of idiopathic respiratory distress syndrome in premature neonates. Eur J Pediatr 1989; 148 (05) 455-458
• 23 Konishi M, Chida S, Shimada S. , et al. Surfactant replacement therapy in premature babies with respiratory distress syndrome: factors affecting the response to surfactant and comparison of outcome from 1982-86 and 1987-91. Acta Paediatr Jpn 1992; 34 (06) 617-630
• 24 Streif W, Paes B, Berry L, Andrew M, Andreasen RB, Chan AK. Influence of exogenous factor VIIa on thrombin generation in cord plasma of full-term and pre-term newborns. Blood Coagul Fibrinolysis 2000; 11 (04) 349-357
• 25 Keir AK, Stanworth SJ. Neonatal plasma transfusion: an evidence-based review. Transfus Med Rev 2016; 30 (04) 174-182